P-Cure signed a development deal with Philips Healthcare to advance its proton therapy using Philips imaging technology. Philips (NYSE:PHG) aligned itself with Israel-based medical device company P-Cure, in order to advance the smaller firm’s proton therapy technology. P-Cure develops low-cost proton therapy systems, which are smaller, cheaper radiation therapy system for targeting cancerous tumors. Founded in 2007, the company won FDA 510(k) clearance in 2010 for it P-Art system.
Help employers find you! Check out all the jobs and post your resume.
